REGENXBIO Inc.

RGNX | NASDAQ

Price Alert Chart Builder DCF Calculator

$7.88

-$0.15 (-1.87%)

At close: Sep 21, 2026, 4:00 PM ET

$7.88

$0 (0.00%)

After-hours: Sep 21, 2026, 7:30 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Revenue	170.44M	83.33M	90.24M	112.72M	470.35M	154.57M
Cost of Revenue	20.3M	33.57M	37.21M	54.55M	51.83M	35.71M
Gross Profit	150.14M	49.76M	53.03M	58.18M	418.51M	118.85M
Operating Income	-161.2M	-233.35M	-268.13M	-262.88M	159.98M	-119.23M
Interest Income	12.27M	174K	25K	342K	719K	4.27M
Pretax Income	-193.88M	-227.1M	-263.65M	-280.41M	141.25M	-106.01M
Net Income	-193.88M	-227.1M	-263.49M	-280.32M	127.84M	-111.25M
Selling & General & Admin	82.86M	76.62M	88.49M	85.28M	79.33M	63.82M
Research & Development	228.3M	208.52M	232.27M	242.45M	181.44M	166.29M
Other Expenses	179K	-2.03M	397K	-6.68M	-2.24M	7.98M
Operating Expenses	311.34M	283.11M	321.16M	321.06M	258.53M	238.09M
Interest Expense	45.01M	12.66M	6.86M	23.25M	26.28M	771K
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	331.64M	316.67M	358.37M	375.6M	310.37M	273.8M
Income Tax Expense	n/a	n/a	-152K	-84K	13.41M	5.24M
Shares Outstanding (Basic)	51.57M	49.51M	43.73M	43.15M	42.44M	37.28M
Shares Outstanding (Diluted)	51.57M	49.51M	43.73M	43.15M	43.91M	37.28M
EPS (Basic)	-3.76	-4.59	-6.02	-6.50	3.01	-2.98
EPS (Diluted)	-3.76	-4.59	-6.02	-6.50	2.91	-2.98
EBITDA	-133.26M	-198.23M	-239.46M	-244.24M	177.09M	-96.83M
EBIT	-148.87M	-214.44M	-256.78M	-257.15M	167.52M	-105.24M
Depreciation & Amortization	15.62M	16.22M	17.32M	12.91M	9.56M	8.41M